|
From: He, Y. <yon...@me...> - 2012-03-31 02:02:40
|
Dear Melanie, Alan, Ryan, and all OAE-developers, As you probably know, there will be two adverse event-related workshops in the ICBO conference: * "Vaccine and Drug Ontology in the Study of Mechanism and Effect" (VDOSME 2012): http://kr-med.org/icbofois2012/vdosme/index.htm * "Methods for adverse events representation Ontology and Information Model": http://kr-med.org/icbofois2012/adverse_events/ In terms of AE study, VDOSME focuses on basic mechanism analysis, and the AE workshop focuses on clinical AE representation. More details are explained here: http://kr-med.org/icbofois2012/vdosme/callforpapers.htm Since last year's AE workshop in the ICBO 2011, we have made a lot of changes on OAE. Of course, the most obvious change is the naming change, from AEO to OAE. Another change is the basic definition of AE in current OAE. The AE definition in the last year's paper is now equivalent to the 'causal adverse event' in OAE. With this and other changes, now OAE and AERO agree on the basic definition of AE now. With all these updates, I propose that we submit a general OAE paper to the AE workshop. This paper will summarize our updates since last year and make some good description of our new OAE development. I am now preparing an outline. Please let me know if you are interested in participating in this paper preparation. The deadline of submission is April 30. So we have about one month. Best regards, Oliver Yongqun "Oliver" He, DVM, PhD Associate Professor Unit for Laboratory Animal Medicine Department of Microbiology and Immunology and Center for Computational Medicine and Bioinformatics University of Michigan Medical School Ann Arbor, MI 48109 Email: yon...@me...<mailto:yon...@me...> Tel: 734-615-8231 (O) http://www.hegroup.org/ ********************************************************** Electronic Mail is not secure, may not be read every day, and should not be used for urgent or sensitive issues |